Skip to main content
    A

    Amphastar P (AMPH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.17
    -0.20 (-0.68%)

    Market Cap: $1.25B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Amphastar P (AMPH) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Amphastar P reported revenue of $719.89M for the fiscal year ended Dec 31, 2025, down 1.7% from the year before. That year, net income was $98.09M with a net margin of 13.6%, operating cash flow was $156.12M and free cash flow was $121.23M. The quarter ended Sep 30, 2026 had revenue of $207.61M and net income of $37.76M.

    Revenue and Margins

    The operating margin was 19.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $255.16M, a compound annual rate of 12.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$719.89M-1.7%49.5%19.5%13.6%
    Dec 2024$731.97M+13.6%51.1%28.1%21.8%
    Dec 2023$644.39M+29.1%54.5%30.6%21.3%
    Dec 2022$498.99M+14.0%49.9%21.5%18.3%
    Dec 2021$437.77M+25.1%45.6%16.0%14.5%
    Dec 2020$349.85M+8.5%41.0%3.1%0.3%
    Dec 2019$322.36M+9.4%40.9%0.0%14.4%
    Dec 2018$294.67M+22.7%36.3%-2.9%-2.3%
    Dec 2017$240.18M-5.9%37.7%-0.5%1.5%
    Dec 2016$255.16MN/A40.8%6.0%3.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 38.5% from the year before. In the quarter ended Sep 2026, net income rose 117.6% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$719.89M$731.97M$644.39M$498.99M$437.77M$349.85M$322.36M$294.67M$240.18M$255.16M
    Cost of revenue$363.83M$358.11M$293.27M$250.13M$238.03M$206.51M$190.43M$187.68M$149.67M$150.97M
    Gross profit$356.06M$373.86M$351.12M$248.86M$199.74M$143.34M$131.92M$106.98M$90.51M$104.20M
    Research and development$85.84M$73.91M$73.74M$74.77M$60.93M$67.23M$68.85M$57.56M$43.50M$41.52M
    Operating income$140.40M$205.42M$196.99M$107.50M$69.89M$10.95M-$39.00K-$8.62M-$1.27M$15.38M
    Net income$98.09M$159.52M$137.54M$91.39M$63.30M$1.10M$46.51M-$6.66M$3.65M$9.82M
    EBITDA$206.98M$272.73M$246.23M$145.31M$111.17M$29.55M$80.47M$6.38M$17.46M$30.06M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$207.61M$183.90M$171.17M$183.10M$191.84M$174.41M$170.53M$186.52M$191.21M$182.39M$171.84M$178.10M
    Gross profit$99.63M$93.47M$70.32M$85.67M$98.65M$86.49M$85.25M$86.65M$101.94M$95.17M$90.10M$96.14M
    Operating income$50.77M$39.73M$13.63M$35.61M$25.32M$42.18M$37.29M$45.14M$57.05M$55.22M$48.01M$53.98M
    Net income$37.76M$30.35M$6.42M$24.43M$17.35M$31.03M$25.29M$37.96M$40.43M$37.95M$43.18M$36.17M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $610.39M exceeded cash and equivalents by $440.21M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.63B$1.58B$1.51B$741.99M$671.53M$631.24M$586.97M$513.56M$451.07M$427.74M
    Current assets$636.02M$534.07M$489.60M$378.32M$318.12M$279.68M$255.24M$220.34M$187.78M$184.10M
    Cash and equivalents$170.18M$151.61M$144.30M$156.10M$126.35M$92.64M$73.69M$86.34M$65.59M$72.35M
    Total liabilities$840.49M$845.17M$873.49M$213.33M$226.01M$182.51M$159.44M$149.20M$117.34M$98.48M
    Short-term debt$1.64M$234.00K$436.00K$3.05M$2.20M$12.26M$7.74M$18.23M$6.31M$5.37M
    Long-term debt$608.75M$601.63M$589.58M$72.84M$74.78M$34.19M$39.39M$31.98M$40.84M$32.36M
    Shareholder equity$788.80M$732.30M$639.42M$528.66M$445.52M$402.31M$381.37M$332.44M$333.74M$329.25M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.71B$1.74B$1.65B$1.63B$1.67B$1.62B$1.63B$1.58B$1.55B$1.49B$1.57B$1.51B
    Total liabilities$897.17M$975.61M$874.77M$840.49M$889.48M$857.85M$874.99M$845.17M$817.50M$778.18M$901.96M$873.49M
    Cash and equivalents$204.59M$223.61M$170.94M$170.18M$216.26M$187.69M$182.78M$151.61M$192.12M$189.62M$201.15M$144.30M
    Shareholder equity$814.55M$768.16M$773.39M$788.80M$776.75M$757.48M$751.28M$732.30M$727.68M$713.35M$672.36M$639.42M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 77.7% of operating cash flow. Share repurchases came to 62.4% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$156.12M$213.39M$183.50M$89.18M$97.99M$57.27M$41.76M$38.19M$39.21M$38.56M
    Capital expenditures$34.88M$41.04M$38.17M$24.03M$27.46M$33.85M$41.55M$46.81M$35.10M$21.38M
    Free cash flow$121.23M$172.34M$145.34M$65.15M$70.54M$23.41M$207.00K-$8.62M$4.11M$17.18M
    Dividends paidN/AN/A$454.09M$15.66M$15.93M$23.16MN/A$20.31M$0$10.20M
    Share repurchases$75.59M$85.46M$58.14M$39.91M$28.87M$24.43M$22.29M$25.05M$30.75M$9.91M
    Investing cash flow-$70.33M-$124.93M-$649.12M-$32.78M-$28.67M-$36.41M-$50.53M-$42.18M-$36.89M-$39.50M
    Financing cash flow-$67.42M-$80.95M$454.09M-$26.44M-$37.02M-$2.25M-$3.78M$25.01M-$7.72M$7.14M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$43.30M$51.32M$47.84M$32.86M$52.58M$35.59M$35.08M$29.02M$59.96M$69.11M$55.29M$23.86M
    Capital expenditures$9.94M$8.59M$9.51M$8.27M$5.35M$10.56M$10.70M$12.41M$13.79M$6.04M$8.79M$9.44M
    Free cash flow$33.36M$42.73M$38.33M$24.59M$47.23M$25.03M$24.38M$16.61M$46.17M$63.06M$46.50M$14.42M
    Last 12 quarters

    Frequently Asked Questions About AMPH

    What is Amphastar P's annual revenue?

    Amphastar P reported revenue of $719.89M for the fiscal year ended Dec 31, 2025.

    How fast is Amphastar P's revenue growing?

    Revenue was down 1.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 13.0%.

    Is Amphastar P profitable?

    Yes. Amphastar P reported net income of $98.09M for the fiscal year ended Dec 31, 2025, with a net margin of 13.6%.

    How much free cash flow does AMPH generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $156.12M minus capital expenditures of $34.88M produced free cash flow of $121.23M.

    How much debt does Amphastar P have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $608.75M, short-term debt of $1.64M and cash and equivalents of $170.18M.